Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
09/2012
09/19/2012CN102670915A Traditional Chinese medicine combination for treating hashimoto thyroiditis
09/19/2012CN102670868A Medicinal plaster for treating allergic dermatitis, anal itching and vulvar itching, and preparation method thereof
09/19/2012CN102670866A Traditional Chinese medicine decoction for treating vaccine-allergic rash
09/19/2012CN102670831A Medicinal composition for treating dermatomyositis and preparation method thereof
09/19/2012CN102670821A Traditional Chinese medicine compound preparation for treating allergic purpura, and preparation method thereof
09/19/2012CN102670793A Chinese herba preparation for increasing cow immunity and reducing milk somatic number and preparation method
09/19/2012CN102670773A Chinese herba preparation for treating scleroderma
09/19/2012CN102670758A Traditional Chinese medicine for treating scleroderma
09/19/2012CN102670747A Chinese medicinal composition for treating canine allergic purpura, and preparation method thereof
09/19/2012CN102670746A Anti-platelet activation traditional Chinese medicine composition for treating lupus erythematosus
09/19/2012CN102670729A Preparation method for cistanche tubulosa and American ginseng compound capsule
09/19/2012CN102670715A Cordyceps sinensis mycelium oral liquid
09/19/2012CN102670683A Chinese medicinal composition for treating allergic rhinitis
09/19/2012CN102670682A Modified highest-grade tribute red ginseng and preparation method thereof
09/19/2012CN102670680A Method for extracting total saponins from bark of acanthopanax brachypus harms
09/19/2012CN102670677A New application of traditional Chinese medicine fennel
09/19/2012CN102670663A Clostridium preparation and application thereof
09/19/2012CN102670662A Uronic acid and probiotics
09/19/2012CN102670639A Novel application of azithromycin
09/19/2012CN102670622A Pharmaceutical composition containing bifonazole for treating superficial mycosis
09/19/2012CN102670587A Application of 7-methoxy-8-isopentenycoumarin in medicine
09/19/2012CN102670556A Tacrolimus osmotic pump type controlled release tablet
09/19/2012CN102670503A Stable emulsion composition
09/19/2012CN102670499A Slow-release sirolimus ophthalmic preparation
09/19/2012CN102670498A Sustained-release sirolimus ophthalmic preparation
09/19/2012CN102670488A Rupatadine syrup composition and preparation method thereof
09/19/2012CN102670456A Multi-effect facial cream and preparation method thereof
09/19/2012CN102670013A Flower fragrance health care pillow
09/19/2012CN102669669A Deer spleen extract preparation and preparation method thereof
09/19/2012CN102283916B Medicament for treating allergic rhinitis and preparation method thereof
09/19/2012CN102228473B Extraction method for active substances in cornua cervi pantotrichum
09/19/2012CN102125147B Health care tea
09/19/2012CN102058852B Medicinal liquor for treating cancer and preparation method thereof
09/19/2012CN102008460B 抗过敏剂 Antiallergic agent
09/19/2012CN101796039B Phenylacetic acid compound
09/19/2012CN101322739B Prescription of Chinese medicine health care capsules mixed with nucleotide and aminoacid and preparing technique
09/19/2012CN101297968B Preparation of pig serum immunoglobulin microsphere novel dosage form
09/19/2012CN101258149B Thiazole derivatives and use thereof
09/18/2012US8268873 Inhibitors of IMPDH enzyme
09/18/2012US8268833 Inhibitors of histone deacetylase
09/18/2012US8268830 Method of using diketopiperazines and composition containing them
09/18/2012US8268829 Substituted pyrimidines useful as protein kinase inhibitors
09/18/2012US8268826 5-({4-[(3S)-4-(5-bromo-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl}carbonyl)-4,6-dimethylpyrimidine; inflammatory diseases, immune diseases and viral infections; HIV
09/18/2012US8268618 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins
09/18/2012US8268331 Nucleic acid molecules and polypeptides for immune modulation
09/18/2012US8268329 Modified Vaccinia ankara virus variant
09/18/2012US8268325 Modified Vaccinia Ankara virus variant
09/18/2012US8268324 Modified galectin 9 proteins and use thereof
09/18/2012CA2603414C Anti-cd20 monoclonal antibody
09/18/2012CA2588417C 2-methylene-18,19-dinor-1.alpha.-hydroxy-homopregnacalciferol and its uses
09/18/2012CA2492325C Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds
09/18/2012CA2490993C Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparations and uses thereof
09/18/2012CA2454750C Immunologically significant herpes simplex virus antigens and methods for using same
09/18/2012CA2296750C Cellular vesicle called ''exosome'', preparation and use thereof in immune stimulation
09/18/2012CA2291483C Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
09/18/2012CA2272051C Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation
09/18/2012CA2226013C Preparations and methods for the treatment of t cell mediated diseases
09/13/2012WO2012122396A1 Novel vaccine adjuvants based on targeting adjuvants to antibodies directly to antigen-presenting cells
09/13/2012WO2012122388A2 Chip-last embedded interconnect structures and methods of making the same
09/13/2012WO2012121678A1 METHOD OF USING CD1d OVER-EXPRESSION IN HUMAN DENDRITIC CELLS TO ENHANCE CD8+ T CELL-BASED AND INVARIANT NATURAL KILLER T CELL- BASED ANTITUMOR IMMUNITY
09/13/2012WO2012120428A1 Novel kinase inhibitors
09/13/2012WO2012120262A1 Compounds and methods for improving impaired endogenous fibrinolysis using histone deacetylase inhibitors
09/13/2012WO2012119983A1 Treatment for ige-mediated disease
09/13/2012WO2012095432A3 Tlr3 binding agents
09/13/2012WO2012072268A3 Anti cd4 antibodies to prevent in particular graft -versus - host - disease (gvhd)
09/13/2012WO2011103524A8 Cyclic tetrapeptides and therapeutic applications thereof
09/13/2012US20120232463 De novo synthesis of bacteriochlorins
09/13/2012US20120232141 Compositions comprising a fatty acid oil mixture and a free fatty acid, and methods and uses thereof
09/13/2012US20120232112 Amino-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals
09/13/2012US20120232093 Pyrazole derivatives as sigma receptor inhibitors
09/13/2012US20120232085 3,4-dihydro-2h-pyrazino[1,2-a]indol-1-one derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
09/13/2012US20120232074 Imidazo [4, 5-C] Quinoline Derivatives As Bromodomain Inhibitors
09/13/2012US20120232072 Imidazopyridine derivatives
09/13/2012US20120232071 2,3-diaryl- or heteroaryl-substituted 1,1,1-trifluoro-2-hydroxypropyl compounds
09/13/2012US20120232067 Benzodiazepinone compounds and methods of treatment using same
09/13/2012US20120232061 Novel compounds
09/13/2012US20120232054 Pyrrolotriazine compounds
09/13/2012US20120232031 Injectable formulations for intra-articular or peri-articular administration
09/13/2012US20120232028 Bicyclic Compound, Production and Use Thereof
09/13/2012US20120232020 METHOD OF IMPROVING TRANSPLANT FUNCTION USING SOLUBLE COMPLEMENT RECEPTOR TYPE I (sCR1)
09/13/2012US20120232004 Methods for Treating Autoimmune Disorders, and Reagents Related Thereto
09/13/2012US20120231999 Peptidic glp-2 agonists
09/13/2012US20120231044 Vaccine formulation of mannose coated peptide particles
09/13/2012US20120231041 Immunomodulating Nanoparticulate Composition
09/13/2012US20120231039 Chimeric immunomodulatory compounds and methods of using the same-iv
09/13/2012US20120231037 Crystalline drug-containing coatings
09/13/2012US20120231036 Cloned biological material medical device and method thereof
09/13/2012US20120231035 Method for inducing cell lysis with immunogenic portions of ny-eso-1 protein
09/13/2012US20120231030 Multi-epitopic vaccine
09/13/2012US20120231029 Enhanced malaria msp-1 subunit vaccine
09/13/2012US20120231028 Polyvalent vaccine
09/13/2012US20120231027 Novel h5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use
09/13/2012US20120231026 Methods and compositions for tumor vaccination and therapy
09/13/2012US20120231025 Vaccine Having a Peptide Adjuvant for Eliciting a Specific Immune Response to Treat Viral Infection and Other Conditions
09/13/2012US20120231023 Novel Vaccine Adjuvants Based on Targeting Adjuvants to Antibodies Directly to Antigen-Presenting Cells
09/13/2012US20120231006 Anti-orai1 antigen binding proteins and uses thereof
09/13/2012US20120231003 Ox2 Receptor Homologs
09/13/2012US20120231000 Truncated cystine-knot proteins
09/13/2012US20120230987 Methods for treating conditions associated with c-fms
09/13/2012US20120230984 Methods of Treating or Preventing Autoimmune Diseases With 2,4-Pyrimidinediamine Compounds
1 ... 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 ... 1172